Enhanced CBTi for Older Adult Sleep and Cognition

NCT05015803 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-04-12

No results posted yet for this study

Summary

This randomized clinical trial on 60+ aged and independent-living healthy individuals with symptoms of insomnia will attempt to improve sleep and health outcomes related to sleep with enhancement of a clinical intervention, Cognitive Behavioral Therapy for Insomnia (CBTi).

Conditions

  • Insomnia
  • Alzheimers Disease Related Dementias

Interventions

COMBINATION_PRODUCT

CBTi with Application

Participants randomized to this study arm will experience an attempted enhancement of standard video conferencing CBTi, that is facilitated with electronic device-based data and resources to the clinician. Noninvasive ambulatory worn and nearable devices deliver feedback of data to the clinician on an application interface. This information will be used to inform the therapeutic approach and to facilitate a living-space environment that is conducive to effective therapy.

BEHAVIORAL

CBTi

Participants randomized to this study arm will experience standard CBTi that is delivered via video conferencing by a clinician, with some application interface use.

BEHAVIORAL

Sleep Hygiene Education

Participants randomized to this study arm will experience sleep hygiene education and training, with some application interface use.

Sponsors & Collaborators

  • University of Arizona

    collaborator OTHER
  • Proactive Life Inc

    collaborator INDUSTRY
  • Penn State University

    lead OTHER

Principal Investigators

  • Daniel Taylor, Ph.D. · The University of Arizona

  • Daniel Gartenberg, Ph.D. · Sleep Space, Inc.

  • Orfeu M Buxton, Ph.D. · The Pennsylvania State University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-16
Primary Completion
2023-06-14
Completion
2023-08-16

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05015803 on ClinicalTrials.gov